Director, President, CEO and Director · ACTUATE THERAPEUTICS, INC. · Common Stock
Side
BUY
Value
$50K
Shares
140.8K
Price
$0.36
Executed
Oct 28, 2026
Disclosed
Oct 29, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 28 executedOct 29, 2026 disclosed
ACTU · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Schmitt Daniel M filed this Form 4 reporting a open-market purchase of ACTU on Oct 28, 2026. It became public on Oct 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President, CEO and Director
Schmitt Daniel Mcik:0001318470
Issuer
ACTUATE THERAPEUTICS, INC.cik:0001652935
Revision history · 0
No field has changed since this record was first ingested.
